Literature DB >> 2867215

Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.

A H Ganong, C W Cotman.   

Abstract

Responses evoked by several amino acid excitants, including the tryptophan metabolite quinolinic acid, were recorded intracellularly from CA1 pyramidal neurons in rat hippocampal slices. Quinolinate, N-methyl-D-aspartate (NMDA), ibotenate and (+/-)-cis-1-amino-1,3-dicarboxycyclopentane produced excitations characterized by burst firing of action potentials, tetrodotoxin-resistant spiking and apparent increases in input resistance measured with brief hyperpolarizing current pulses. L-Glutamate, kainate, quisqualate and (+/-)-2'-amino-3-hydroxy-5-methyl-4-isoxazole-3'-propionate depolarized CA1 pyramidal neurons and induced apparent decreases in input resistance. Quinolinate-, NMDA-, and ibotenate-induced focal depolarizations, but not L-glutamate, kainate- or quisqualate-induced responses, were strongly antagonized by specific NMDA receptor antagonists. The tryptophan metabolite kynurenic acid, at concentrations that antagonized focal depolarizations produced by NMDA, ibotenate and the endogenous excitant quinolinate, did not antagonize quisqualate or L-glutamate responses. In addition to its NMDA-type antagonist action, kynurenate blocked kainate-induced focal depolarizations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867215

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  35 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro.

Authors:  E J Fletcher; D Martin; J A Aram; D Lodge; T Honoré
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Optical detection of postsynaptic potentials evoked by vagal stimulation in the early embryonic chick brain stem slice.

Authors:  H Komuro; T Sakai; Y Momose-Sato; A Hirota; K Kamino
Journal:  J Physiol       Date:  1991-10       Impact factor: 5.182

Review 4.  Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.

Authors:  Edson X Albuquerque; Robert Schwarcz
Journal:  Biochem Pharmacol       Date:  2012-12-25       Impact factor: 5.858

5.  Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.

Authors:  Sara K Olsson; Markus K Larsson; Sophie Erhardt
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

6.  Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.

Authors:  Maria Holtze; Peter Saetre; Göran Engberg; Lilly Schwieler; Thomas Werge; Ole A Andreassen; Håkan Hall; Lars Terenius; Ingrid Agartz; Erik G Jönsson; Martin Schalling; Sophie Erhardt
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

7.  Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea-pig hippocampus.

Authors:  C W Cotman; J A Flatman; A H Ganong; M N Perkins
Journal:  J Physiol       Date:  1986-09       Impact factor: 5.182

8.  Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism.

Authors:  Jane Y Chen; Conny Tran; Lin Hwang; Gang Deng; Michael E Jung; Kym F Faull; Michael S Levine; Carlos Cepeda
Journal:  J Huntingtons Dis       Date:  2016

9.  A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro.

Authors:  N R Burton; D A Smith; T W Stone
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Actions of excitatory amino acid antagonists on geniculo-cortical transmission in the cat's visual cortex.

Authors:  K Hagihara; T Tsumoto; H Sato; Y Hata
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.